Seizert Capital Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-460,261	Closed	-$16.7M	–	241
2016 Q4	$16.7M	Buy	460,261 +68,561	+18%	+$2.74M	0.59%	53
2016 Q3	$18M	Buy	391,700 +181,606	+86%	+$9.48M	0.67%	52
2016 Q2	$10.6M	Buy	210,094 +60,224	+40%	+$3.21M	0.4%	65
2016 Q1	$8.02M	Buy	149,870 +42,384	+39%	+$2.49M	0.27%	75
2015 Q4	$7.05M	Sell	107,486 -8,051	-7%	-$498K	0.22%	81
2015 Q3	$6.52M	Sell	115,537 -51,391	-31%	-$3.33M	0.2%	85
2015 Q2	$9.87M	Buy	166,928 +5,141	+3%	+$317K	0.25%	79
2015 Q1	$10.1M	Sell	161,787 -2,781	-2%	-$162K	0.25%	81
2014 Q4	$9.46M	Buy	164,568 +182	+0.1%	+$10.1K	0.2%	81
2014 Q3	$8.84M	Sell	164,386 -5,149	-3%	-$273K	0.18%	83
2014 Q2	$8.89M	Buy	169,535 +72,807	+75%	+$3.72M	0.18%	81
2014 Q1	$5.11M	Buy	+96,728	New	+$4.47M	0.12%	79
2013 Q3	–	Sell	-7,960	Closed	-$312K	–	214
2013 Q2	$312K	Buy	+7,960	New	+$310K	0.01%	167